Table 2.

Recorded primary and secondary outcomes, overall and by year of surgical procedure (2020 versus 2019)

	Total sample	March–December 2019	March–December 2020	P*
	(n = 3236)	(n = 1755)	(n = 1481)
Primary outcomes
Cancer TNM stage				0.614
Early	51.4	51.7	50.9
Advanced	48.6	48.3	49.1
Palliative surgery	6.2	5.0	7.5	0.003
Secondary outcomes
Symptoms at diagnosis	82.5	80.8	84.5	0.006
Clinical T4 stage	7.4	6.2	8.7	0.008
Liver metastasis	10.2	10.2	10.3	0.889
	(n = 3101)	(n = 1642)	(n = 1459)
Multiple liver metastases†	76.7	72.1	82.2	0.029
	(n = 331)	(n = 179)	(n = 152)
Lung metastasis	3.7	3.0	4.4	0.038
Surgical complications	33.3	34.4	31.9	0.151
Emergency surgery	90.2	91.0	89.2	0.079
30-day death	2.0	1.7	2.4	0.149

Values are percentages. ^†Including only the 331 patients with liver metastasis. *Chi-squared test.